Russell Investments Group, Ltd. Prometheus Biosciences, Inc. Transaction History

Russell Investments Group, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$103.46 - $126.29 $1.66 Million - $2.02 Million	16,020 Added 36.68%	59,697 $6.41 Million
Q4 2022 Feb 08, 2023	SELL	$36.06 - $117.21 $1.46 Million - $4.75 Million	-40,499 Reduced 48.11%	43,677 $4.8 Million
Q3 2022 Nov 04, 2022	BUY	$28.17 - $59.01 $1.28 Million - $2.68 Million	45,466 Added 117.45%	84,176 $4.96 Million
Q2 2022 Jul 29, 2022	SELL	$22.39 - $38.94 $459,129 - $798,503	-20,506 Reduced 34.63%	38,710 $1.09 Million
Q1 2022 May 05, 2022	BUY	$30.13 - $50.0 $1.78 Million - $2.96 Million	59,216 New	59,216 $2.23 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.